BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8482564)

  • 1. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides.
    Watson JM; Berek JS; Martínez-Maza O
    Gynecol Oncol; 1993 Apr; 49(1):8-15. PubMed ID: 8482564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures.
    Watson JM; Sensintaffar JL; Berek JS; Martínez-Maza O
    Cancer Res; 1990 Nov; 50(21):6959-65. PubMed ID: 2208162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism.
    Kong B; Isozaki T; Sasaki S
    Gynecol Oncol; 1996 Oct; 63(1):78-84. PubMed ID: 8898173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 alpha and beta genes.
    Li BY; Mohanraj D; Olson MC; Moradi M; Twiggs L; Carson LF; Ramakrishnan S
    Cancer Res; 1992 Apr; 52(8):2248-52. PubMed ID: 1559228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The study of relationship between c-erbB2 expression and cytoimmunology in ovarian carcinoma and its antisense regulation].
    Jin Z; Zhang X; Feng Y
    Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):222-4. PubMed ID: 7664609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
    Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells.
    Wang Y; Yang J; Gao Y; Du Y; Bao L; Niu W; Yao Z
    Cell Mol Immunol; 2005 Oct; 2(5):365-72. PubMed ID: 16368063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer.
    Popadiuk CM; Xiong J; Wells MG; Andrews PG; Dankwa K; Hirasawa K; Lake BB; Kao KR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2216-23. PubMed ID: 16609037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
    Levy Y; Tsapis A; Brouet JC
    J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin-6 on the growth of human lung cancer cell line.
    Fu J; Zheng J; Fang W; Wu B
    Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L; Gudas LJ
    J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines.
    Skilling JS; Squatrito RC; Connor JP; Niemann T; Buller RE
    Gynecol Oncol; 1996 Jan; 60(1):72-80. PubMed ID: 8557231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
    Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
    Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 as an autocrine stimulator in the growth of human ovarian cancer cells.
    Kawakami Y; Nagai N; Ota S; Ohama K; Yamashita U
    Hiroshima J Med Sci; 1997 Mar; 46(1):51-9. PubMed ID: 9114567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
    Huang M; Stolina M; Sharma S; Mao JT; Zhu L; Miller PW; Wollman J; Herschman H; Dubinett SM
    Cancer Res; 1998 Mar; 58(6):1208-16. PubMed ID: 9515807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
    Keller ET; Ershler WB
    J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
    Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
    Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.